Skip to main content

Peer Review reports

From: Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia

Original Submission
22 Jan 2020 Submitted Original manuscript
12 Feb 2020 Reviewed Reviewer Report - Graham Bothamley
17 Feb 2020 Reviewed Reviewer Report - Barbara Castelnuovo
22 Feb 2020 Reviewed Reviewer Report - Varduhi Ghazaryan
10 Mar 2020 Reviewed Reviewer Report - Pushpendra Singh
11 Apr 2020 Author responded Author comments - Julia Ershova
Resubmission - Version 2
11 Apr 2020 Submitted Manuscript version 2
20 Apr 2020 Reviewed Reviewer Report - Pushpendra Singh
21 Apr 2020 Reviewed Reviewer Report - Barbara Castelnuovo
23 Apr 2020 Reviewed Reviewer Report - Graham Bothamley
15 Jun 2020 Author responded Author comments - Julia Ershova
Resubmission - Version 3
15 Jun 2020 Submitted Manuscript version 3
7 Jul 2020 Author responded Author comments - Julia Ershova
Resubmission - Version 4
7 Jul 2020 Submitted Manuscript version 4
Publishing
9 Jul 2020 Editorially accepted
25 Jul 2020 Article published 10.1186/s12879-020-05243-9

You can find further information about peer review here.

Back to article page